Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.

A Stokes, William; R Bronsert, Michael; A Meguid, Robert; G Blum, Matthew; L Jones, Bernard; Koshy, Matthew; J Sher, David; V Louie, Alexander; A Palma, David; Senan, Suresh; E Gaspar, Laurie; D Kavanagh, Brian; G Rusthoven, Chad

doi:10.1200/jco.2017.75.6536

Public

Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.

Published in Journal of clinical oncology : official journal of the American Society of Clinical Oncology • Mar 1, 2018

NobleIDark:/48914/w1/20260526/C5A7D08BRecord on NobleID

Authors:

William A Stokes

,

Michael R Bronsert

,

Robert A Meguid

Abstract

Purpose In early-stage non-small cell lung cancer (NSCLC), post-treatment mortality may influence the comparative effectiveness of surgery and stereotactic body radiotherapy (SBRT), with implications for shared decision making among high-risk surgical candidates. We analyzed early mortality after th...

Discussions